Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yuto Terashima, MD"'
Autor:
Tsuyoshi Hirata, MD, Yuji Uehara, MD, Taiki Hakozaki, MD, Takayuki Kobayashi, MD, Yuto Terashima, MD, Kageaki Watanabe, MD, Makiko Yomota, MD, PhD, Yukio Hosomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100659- (2024)
Introduction: Previous studies reported an association between immune checkpoint inhibitor infusion timing and the treatment effect in metastatic NSCLC. The present study assessed the association between durvalumab infusion timing and survival outcom
Externí odkaz:
https://doaj.org/article/f8d1f14e741e43bb923d8e88043d79bf
Autor:
Yuto Terashima, MD, Masaru Matsumoto, MD, PhD, Hiroki Iida, MD, Sae Takashima, MD, Aya Fukuizumi, MD, PhD, Susumu Takeuchi, MD, PhD, Akihiko Miyanaga, MD, PhD, Yasuhiro Terasaki, MD, PhD, Kazuo Kasahara, MD, PhD, Masahiro Seike, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 11, Pp 100578- (2023)
Introduction: Pervious studies reported the association of TTF-1 expression with the efficacy of platinum-doublet chemotherapy in combination with immune checkpoint inhibitors in advanced nonsquamous NSCLC. Nevertheless, the predictive value of exten
Externí odkaz:
https://doaj.org/article/a8d24f9941d1407ebf190954c5f35839